Systems Biology Guided Therapy for Breast Cancer Positive for Oestrogen Receptor After Aromatase Inhibitor and CDK Inhibition
Status: RECRUITING
Study type: INTERVENTIONAL
Conditions: Breast Cancer|Estrogen Receptor-positive Breast Cancer|HER2-negative Breast Cancer
Interventions: DRUG: Drug determined by treating oncologist based on recommendation from systems biology analysis.
Sponsor: Inova Health Care Services
Collaborators: City of Hope Medical Center